Home > Cashflow Statement > CONCORD BIOTECH

CONCORD BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹267 Cr₹245 Cr₹265 Cr₹246 Cr₹207 Cr

What is the latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH ?

The latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH is ₹267 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹267 Cr
Mar2025₹245 Cr
Mar2024₹265 Cr
Mar2023₹246 Cr
Mar2022₹207 Cr

How is Cash Flow from Operating Activities of CONCORD BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹267 Cr
9.15
Mar2025 ₹245 Cr
-7.89
Mar2024 ₹265 Cr
7.91
Mar2023 ₹246 Cr
18.57
Mar2022 ₹207 Cr -

Compare Cash Flow from Operating Activities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,856.3 Cr 13% 10.6% -30.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,993.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

13%

10.6%

-30.9%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses